Physician

Al Robert Franco, M.D.

According to 2025 Medicare claims, Al Franco, M.D. (NPI: 1528128535) practices rheumatology in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from Riverside, CA. This provider's primary affiliated billing organization is ARTHRITIS CENTER OF RIVERSIDE MEDICAL CORPORATION (NPI: 1013076850; TIN: 33-0489722) and primary practice location at 92505-7101.

Franco's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 257 traditional Medicare patients, billed 63,495 HCPCS/CPT codes, and received $1,035,220 in Medicare payments. The top billing code was 83090 (Homocysteine (amino acid) level). Part D data shows 765 prescription claims across 110 beneficiaries totaling $415,384 in drug costs, led by Otezla (Apremilast). Open Payments data shows 44 records totaling $1,013. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $166,182 and ending at $415,384. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$544K$1.1M2015 Medicare payment: $957,010 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,088,719 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $720,778 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $651,914 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $679,968 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $593,381 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $678,379 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $681,084 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $559,395 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,035,220 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201523748,155$957,010
201622255,213$1,088,719
201717036,437$720,778
201816634,227$651,914
201917239,180$679,968
202020235,751$593,381
202120641,215$678,379
202221541,516$681,084
202321834,213$559,395
202425763,495$1,035,220

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$208K$415K2015 Drug cost: $166,182 (USD; Tot_Drug_Cst)2016 Drug cost: $270,212 (USD; Tot_Drug_Cst)2017 Drug cost: $367,862 (USD; Tot_Drug_Cst)2018 Drug cost: $197,963 (USD; Tot_Drug_Cst)2019 Drug cost: $322,845 (USD; Tot_Drug_Cst)2020 Drug cost: $198,561 (USD; Tot_Drug_Cst)2021 Drug cost: $130,024 (USD; Tot_Drug_Cst)2022 Drug cost: $173,942 (USD; Tot_Drug_Cst)2023 Drug cost: $203,124 (USD; Tot_Drug_Cst)2024 Drug cost: $415,384 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151781,456$166,182
20161351,207$270,212
2017128916$367,862
2018118747$197,963
2019101606$322,845
2020106661$198,561
2021110748$130,024
2022110624$173,942
202390524$203,124
2024110765$415,384

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
83090Homocysteine (amino acid) level247830$17
83520Measurement of substance using immunoassay technique2471,652$17
82728Ferritin (blood protein) level247830$13
86160Measurement of complement (immune system proteins), antigen,2471,654$12
82784Gammaglobulin (immune system protein) measurement2472,481$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast16480$83,483
Humira(Cf) PenAdalimumab12336$81,410
LeflunomideLeflunomide432,021$2,420
Minocycline HclMinocycline Hcl1114,368$2,150
AzithromycinAzithromycin703,040$1,680

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.44$1,013ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Al Robert Franco, M.D.?

Tedicare shows public-source Medicare data for Al Robert Franco, M.D. (NPI 1528128535), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Al Robert Franco, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Al Robert Franco, M.D.?

Al Robert Franco, M.D. is linked to ARTHRITIS CENTER OF RIVERSIDE MEDICAL CORPORATION (billing NPI 1013076850) in the available physician profile data.

Does Al Robert Franco, M.D. have Open Payments data?

Al Robert Franco, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.